Translational Research in Oncology-US
$9.7M
Revenue
13
Filings
Latest Financial Summary
| Fiscal Year | Revenue | Expenses | Net Assets | Contributions |
|---|---|---|---|---|
| FY 2024 | $9.7M | $9.6M | $17.1M | $9.3M |
Key Officers
D
DENNIS SLAMON
President/Se
J
JOHN GLASPY
Vice President
M
MEGHAN BRENNAN
COO
Filing History
IRS990PF
FY 2024
IRS990PF
FY 2023
990PF
FY 2022
990PF
FY 2021
Period ended 2021-12-31
IRS990PF
FY 2020
IRS990PF
FY 2019
990PF
FY 2018
Period ended 2018-12-31
990PF
FY 2017
Period ended 2017-12-31
990PF
FY 2017
Period ended 2017-12-31
990PF
FY 2016
Period ended 2016-12-31
990PF
FY 2015
Period ended 2015-12-31
990PF
FY 2014
Period ended 2014-12-31
990PF
FY 2013
Period ended 2013-12-31
Similar Organizations
Medical Research · CA
CANCER SOLUTIONS RESEARCH INC
SANTA ROSA
OFFICE OF CHAMORRO AFFAIRS INC
SAN DIEGO
RELATIONSHIP DEVELOPMENT RESEARCH INSTITUTE
LOS ANGELES
BOARDING FOR BREAST CANCER INC
LOS ANGELES
